168 related articles for article (PubMed ID: 19260034)
1. Pharmacokinetic and pharmacodynamic study of morphine and morphine 6-glucuronide after oral and intravenous administration of morphine in children with cancer.
Mashayekhi SO; Ghandforoush-Sattari M; Routledge PA; Hain RD
Biopharm Drug Dispos; 2009 Apr; 30(3):99-106. PubMed ID: 19260034
[TBL] [Abstract][Full Text] [Related]
2. Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain.
Quigley C; Joel S; Patel N; Baksh A; Slevin M
Palliat Med; 2003 Mar; 17(2):185-90. PubMed ID: 12701850
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphine.
Meineke I; Freudenthaler S; Hofmann U; Schaeffeler E; Mikus G; Schwab M; Prange HW; Gleiter CH; Brockmöller J
Br J Clin Pharmacol; 2002 Dec; 54(6):592-603. PubMed ID: 12492606
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic modeling to predict morphine and morphine-6-glucuronide plasma concentrations in healthy young volunteers.
Lötsch J; Skarke C; Schmidt H; Liefhold J; Geisslinger G
Clin Pharmacol Ther; 2002 Aug; 72(2):151-62. PubMed ID: 12189362
[TBL] [Abstract][Full Text] [Related]
5. The bioavailability and pharmacokinetics of subcutaneous, nebulized and oral morphine-6-glucuronide.
Penson RT; Joel SP; Roberts M; Gloyne A; Beckwith S; Slevin ML
Br J Clin Pharmacol; 2002 Apr; 53(4):347-54. PubMed ID: 11966664
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of oral morphine and its glucuronides in children receiving morphine as immediate-release liquid or sustained-release tablets for cancer pain.
Hunt A; Joel S; Dick G; Goldman A
J Pediatr; 1999 Jul; 135(1):47-55. PubMed ID: 10393603
[TBL] [Abstract][Full Text] [Related]
7. Morphine, morphine-6-glucuronide and morphine-3-glucuronide pharmacokinetics in newborn infants receiving diamorphine infusions.
Barrett DA; Barker DP; Rutter N; Pawula M; Shaw PN
Br J Clin Pharmacol; 1996 Jun; 41(6):531-7. PubMed ID: 8799518
[TBL] [Abstract][Full Text] [Related]
8. Influences on serum concentrations of morphine, M6G and M3G during routine clinical drug monitoring: a prospective survey in 300 adult cancer patients.
Klepstad P; Dale O; Kaasa S; Zahlsen K; Aamo T; Fayers P; Borchgrevink PC
Acta Anaesthesiol Scand; 2003 Jul; 47(6):725-31. PubMed ID: 12803591
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of morphine and its glucuronides following intravenous administration of morphine in patients undergoing continuous ambulatory peritoneal dialysis.
Pauli-Magnus C; Hofmann U; Mikus G; Kuhlmann U; Mettang T
Nephrol Dial Transplant; 1999 Apr; 14(4):903-9. PubMed ID: 10328468
[TBL] [Abstract][Full Text] [Related]
10. Morphine and morphine-6-glucuronide in the plasma and cerebrospinal fluid of children.
Hain RD; Hardcastle A; Pinkerton CR; Aherne GW
Br J Clin Pharmacol; 1999 Jul; 48(1):37-42. PubMed ID: 10383558
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic modeling of M6G formation after oral administration of morphine in healthy volunteers.
Lötsch J; Weiss M; Ahne G; Kobal G; Geisslinger G
Anesthesiology; 1999 Apr; 90(4):1026-38. PubMed ID: 10201674
[TBL] [Abstract][Full Text] [Related]
12. The transfer half-life of morphine-6-glucuronide from plasma to effect site assessed by pupil size measurement in healthy volunteers.
Lötsch J; Skarke C; Schmidt H; Grösch S; Geisslinger G
Anesthesiology; 2001 Dec; 95(6):1329-38. PubMed ID: 11748388
[TBL] [Abstract][Full Text] [Related]
13. Blood-brain barrier permeability to morphine-6-glucuronide is markedly reduced compared with morphine.
Wu D; Kang YS; Bickel U; Pardridge WM
Drug Metab Dispos; 1997 Jun; 25(6):768-71. PubMed ID: 9193881
[TBL] [Abstract][Full Text] [Related]
14. Distribution of morphine 6-glucuronide and morphine across the blood-brain barrier in awake, freely moving rats investigated by in vivo microdialysis sampling.
Aasmundstad TA; Mørland J; Paulsen RE
J Pharmacol Exp Ther; 1995 Oct; 275(1):435-41. PubMed ID: 7562582
[TBL] [Abstract][Full Text] [Related]
15. Plasma concentrations and renal clearance of morphine, morphine-3-glucuronide and morphine-6-glucuronide in cancer patients receiving morphine.
Somogyi AA; Nation RL; Olweny C; Tsirgiotis P; van Crugten J; Milne RW; Cleary JF; Danz C; Bochner F
Clin Pharmacokinet; 1993 May; 24(5):413-20. PubMed ID: 8504624
[TBL] [Abstract][Full Text] [Related]
16. Disposition of morphine-6-glucuronide and morphine in healthy volunteers.
Hanna MH; Peat SJ; Knibb AA; Fung C
Br J Anaesth; 1991 Jan; 66(1):103-7. PubMed ID: 1997044
[TBL] [Abstract][Full Text] [Related]
17. Effect of P-glycoprotein modulation on the clinical pharmacokinetics and adverse effects of morphine.
Drewe J; Ball HA; Beglinger C; Peng B; Kemmler A; Schächinger H; Haefeli WE
Br J Clin Pharmacol; 2000 Sep; 50(3):237-46. PubMed ID: 10971308
[TBL] [Abstract][Full Text] [Related]
18. Contribution of morphine-6-glucuronide to antinociception following intravenous administration of morphine to healthy volunteers.
Murthy BR; Pollack GM; Brouwer KL
J Clin Pharmacol; 2002 May; 42(5):569-76. PubMed ID: 12017351
[TBL] [Abstract][Full Text] [Related]
19. Comparative disposition of morphine-3-glucuronide during separate intravenous infusions of morphine and morphine-3-glucuronide in sheep. Importance of the kidney.
Milne RW; McLean CF; Mather LE; Nation RL; Runciman WB; Rutten AJ; Somogyi AA
Drug Metab Dispos; 1995 Mar; 23(3):334-42. PubMed ID: 7628298
[TBL] [Abstract][Full Text] [Related]
20. Influence of renal failure on the disposition of morphine, morphine-3-glucuronide and morphine-6-glucuronide in sheep during intravenous infusion with morphine.
Milne RW; McLean CF; Mather LE; Nation RL; Runciman WB; Rutten AJ; Somogyi AA
J Pharmacol Exp Ther; 1997 Aug; 282(2):779-86. PubMed ID: 9262341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
